发明名称 |
Sustained release information. |
摘要 |
The present invention provides a pharmaceutical preparation in tablet form, where the active ingredient is an anti-epileptic medication, preferably a sustained release formulation, and most preferably a sustained release formulation where the active ingredient is carbamazepine. The product consists of carbamazepine particles coated with a single hydrophobic layer and is in a disintegrating tablet form. <IMAGE> |
申请公布号 |
ZA200001852(B) |
申请公布日期 |
2001.02.20 |
申请号 |
ZA20000001852 |
申请日期 |
2000.04.12 |
申请人 |
TARO PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
DANIELA LICHT;MARINA ZHOLKOVSKY;ROMAN KAPLAN;MICHAEL FRIEDMAN;ABRAHAM YACOBI;YECHIEL GOLANDER;DAN MOROS;BARIE LEVITT |
分类号 |
A61K9/16;A61K9/20;A61K9/26 |
主分类号 |
A61K9/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|